Trigeminal Neuralgia study: Deep brain stimulation
Official title Deep Brain Stimulation for Refractory Trigeminal Neuralgia with a Pontine Lesion
ClinicalTrials.gov ID: NCT05451251
What this study is testing
- Who it's for
- People with severe facial pain from a specific type of brain injury, often linked to multiple sclerosis.
- What's involved
- Surgeons will place a small device in the brain to send electrical signals that may reduce pain signals.
- Time commitment
- The study involves surgery and follow-up visits to check how the device is working.
- Phase 1: an early, usually small safety study
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Adults of at least 18 years old
- Refractory trigeminal neuralgia : failure of at least 3 drugs and at least two lesioning surgical interventions (radiosurgery, percutaneous...
- Pontine lesion proved by MRI in contact with trigeminal nerve tract
You likely can't join if
- Absolute contraindication to MRI
- Medical contraindication to the procedure
The study team makes the final eligibility decision.
Where it is enrolling
- Sherbrooke, Quebec, Canada
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Sherbrooke, Quebec, Canada. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.